{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-010080","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2026-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.039170+00:00","generated_at":"2026-05-15T12:28:15.990189+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bone Biologics files prospectus supplement for ATM offering of up to $1.064M in common stock","bullets":["Filing covers up to $1,064,000 shares of common stock sold at market through H.C. Wainwright as sales agent.","Company previously sold $1.7M under prior shelf; new supplement uses Form S-3 declared effective Sept 2025.","Proceeds from ATM offering will be used for general corporate purposes (not specified further).","Legal opinion of Harter Secrest & Emery LLP on share legality filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-010080","json":"https://secwatch.observer/filing/0001493152-26-010080.json","markdown":"https://secwatch.observer/filing/0001493152-26-010080.md","text":"https://secwatch.observer/filing/0001493152-26-010080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226010080/0001493152-26-010080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226010080/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:28:15.990189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}